These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1657508

  • 1. A virus-particle vaccine prepared from bovine mammillitis virus against herpes genitalis.
    Skinner GR, Buchan A, Davies J, Durham J, Castrucci G.
    Comp Immunol Microbiol Infect Dis; 1991; 14(2):133-50. PubMed ID: 1657508
    [Abstract] [Full Text] [Related]

  • 2. Role of bovine mammillitis virus towards preparation of an alternative vaccine against herpes simplex virus infections of human subjects.
    Skinner GR, Buchan A, Durham J, Cowan M, Davies J, Brookes K, Castrucci G.
    Vaccine; 1987 Mar; 5(1):55-9. PubMed ID: 3033927
    [Abstract] [Full Text] [Related]

  • 3. Modification of the genital herpes infection in a guinea pig model, by prior immunization with bovine herpes mammillitis virus.
    Maragos C, May JT.
    Microbiol Immunol; 1988 Mar; 32(5):547-50. PubMed ID: 2845232
    [Abstract] [Full Text] [Related]

  • 4. Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
    Skinner GR, Woodman CB, Hartley CE, Buchan A, Fuller A, Durham J, Synnott M, Clay JC, Melling J, Wiblin C, Wilkins J.
    Br J Vener Dis; 1982 Dec; 58(6):381-6. PubMed ID: 6293640
    [Abstract] [Full Text] [Related]

  • 5. Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis.
    Skinner GR, Fink C, Melling J, Wiblin C, Thornton B, Hallworth J, Gardner W, McLeish P, Hartley C, Buchan A.
    Med Microbiol Immunol; 1992 Dec; 180(6):305-20. PubMed ID: 1549071
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection.
    Mertz GJ, Ashley R, Burke RL, Benedetti J, Critchlow C, Jones CC, Corey L.
    J Infect Dis; 1990 Apr; 161(4):653-60. PubMed ID: 2181031
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of an inactivated vaccine for equine herpesvirus type 1 in a novel hamster model.
    Skinner GR, Davies J.
    Intervirology; 2000 Apr; 43(1):27-35. PubMed ID: 10773735
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trial.
    Skinner GR, Turyk ME, Benson CA, Wilbanks GD, Heseltine P, Galpin J, Kaufman R, Goldberg L, Hartley CE, Buchan A.
    Med Microbiol Immunol; 1997 Jun; 186(1):31-6. PubMed ID: 9255764
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection.
    Bernstein DI, Tepe ER, Mester JC, Arnold RL, Stanberry LR, Higgins T.
    Vaccine; 1999 Apr 09; 17(15-16):1964-9. PubMed ID: 10217595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.